Tamsulosin Dosage for Medical Expulsive Therapy (MET)
The recommended dosage of tamsulosin for medical expulsive therapy of ureteral stones is 0.4 mg once daily, taken approximately one-half hour following the same meal each day. 1
Dosing Specifics
- Standard dose: Tamsulosin 0.4 mg orally once daily 1, 2, 3, 4
- Administration timing: Take approximately 30 minutes after the same meal each day to optimize absorption and minimize variability 1
- Capsule administration: Do not crush, chew, or open the capsules 1
- Duration: Typically administered for 28 days (4 weeks) in clinical trials 2, 4, 5
Clinical Context and Efficacy
Alpha-blockers like tamsulosin are most beneficial for distal ureteral stones greater than 5 mm in diameter. 6
Stone Size Considerations:
- Stones >5 mm: Tamsulosin demonstrates significant benefit with stone expulsion rates of 83-86% versus 61-79% with placebo 2, 4, 7
- Stones ≤5 mm: No significant benefit demonstrated; spontaneous passage rates are similar to placebo 2, 7
Evidence Quality:
The evidence is mixed, with recent large multicenter trials showing conflicting results 3, 4. However, the most comprehensive meta-analysis of 56 randomized controlled trials (9,395 patients) demonstrates that tamsulosin significantly increases stone expulsion rates (RR 1.44), shortens expulsion time, and reduces ureteral colic episodes specifically for stones 5-10 mm 7.
Important Clinical Caveats
Duration of Therapy:
- Optimal treatment window: Most stones that will pass with MET do so within the first 3 weeks 5
- Re-evaluation timing: If the stone has not passed by 3-4 weeks, consider alternative interventions rather than prolonging MET, as this increases emergency department visits, analgesic use, and costs without significant additional benefit 5
Drug Interactions:
- Avoid combination with strong CYP3A4 inhibitors (e.g., ketoconazole) 1
- If therapy is interrupted for several days, restart at 0.4 mg once daily rather than resuming at a higher dose 1
Alternative Dosing:
While some studies have evaluated lower doses (0.2 mg once or twice daily), these showed comparable efficacy to the standard 0.4 mg dose 8. However, the FDA-approved and guideline-supported dose remains 0.4 mg once daily 1.
Off-Label Use Acknowledgment
Note that tamsulosin use for MET represents off-label, class-effect prescribing, as the FDA approval is specifically for benign prostatic hyperplasia, not ureteral stones 6, 1. The European Association of Urology guidelines acknowledge this off-label use with a strong recommendation for stones >5 mm in the distal ureter 6.